A phase II , multicenter study of lazertinib as consolidation therapy in patients with locally advanced, unresectable, EGFR mutation‐positive non‐small cell lung cancer (stage III ) who have not progressed following definitive, platinum‐based, chemoradiation therapy ( PLATINUM trial)
Journal article published in 2022 by
Juwhan Choi,
Jeong Eun Lee 
,
Chang‐Min Choi ,
In‐Jae Oh ,
Kye Young Lee,
Tae Won Jang,
Seung Hyeun Lee ,
Eun Young Kim,
Dong Won Park,
Sun Hyo Park,
Sung Yong Lee
,
Chang‐Min Choi ,
In‐Jae Oh ,
Kye Young Lee,
Tae Won Jang,
Seung Hyeun Lee ,
Eun Young Kim,
Dong Won Park,
Sun Hyo Park,
Sung Yong Lee
This paper is made freely available by the publisher.
Full text: Download
Data provided by 